Preclinical study of the human recombinant Erythropoietin (GBPD002) compared with Eprex
K. Nag, M. Mohiuddin, M. M. R. Khan, S. Kumar, M. E. H. Sarker, R. Roy, B. K. Biswas, U. Barman, N. Sultana, S. C. Bachar, S. R. Haq
This study compares the safety and toxicity of GBPD002 and Eprex(R), two recombinant human erythropoietins, in rats, finding similar toxicological profiles and no significant differences.
bioRxiv · Jun 5, 2024 · PreprintPharmacology & Toxicology